Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

PICC Insertion and Management in Hodgkin Lymphoma Patients: A 10-YEARS Monocentric Prospective Study

Daniele Derudas, MD, Stefania Massidda, Giuseppe Longhitano, Daniela Ibba, Giovanni Caocci, MD, Emanuele Angelucci, MD, Giorgio La Nasa, MD

Blood (2018) 132 (Supplement 1): 5844.

https://doi.org/10.1182/blood-2018-99-115330

Published: 2018

Journal Articles

The Long-Term Adverse Event Profile of Oral Eliglustat for the Treatment of Gaucher Disease Type 1: Pooled Analysis of Data from 393 Patients in 4 Completed Trials

M. Judith Peterschmitt, MD, Selena Freisens, MD, Audrey W Hou, PharmD, Lisa Underhill, MS, Meredith C. Foster, ScD, Sebastiaan J.M. Gaemers, MD

Blood (2018) 132 (Supplement 1): 3692.

https://doi.org/10.1182/blood-2018-99-118319

Published: 2018

Journal Articles

Identification and Characterization of Novel Rare Nucleophosmin ( NPM1 ) Gene Mutations in Acute Myeloid Leukemia (AML) By a Combinatorial Approach of Immunohistochemistry and Molecular Analyses

Maria Paola Martelli, MD PhD, Roberta Rossi, PhD, Emanuela Varasano, PhD, Giorgina Specchia, MD, Francesco Di Raimondo, MD, Giuseppe Avvisati, MD, Enrico Tiacci, MD PhD, Franca Falzetti, MD, Paolo Sportoletti, MD PhD, Brunangelo Falini, MD

Blood (2016) 128 (22): 1717.

https://doi.org/10.1182/blood.V128.22.1717.1717

Published: 2016

Journal Articles

Deguelin Induced Differentiation of NPM1-Mutant AML In Vivo and in Vitro

Xia Zhang, MD PhD, Zichu Zhao, MD PhD, Sha Yi, MD PhD, Lu Wen, MD PhD, Jing He, MD PhD, Jingyu Hu, MD PhD, Jun Ruan, MD PhD, Jun Fang, MD PhD, Yan Chen, MD PhD

Blood (2016) 128 (22): 4030.

https://doi.org/10.1182/blood.V128.22.4030.4030

Published: 2016

Journal Articles

Peripherally Inserted Central Catheters (PICCs) Implantation in the Clinical Management of Oncohematologic Patients: Results of a Large Multicenter, Retrospective Study of the REL Group (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)

Nicola Stefano Fracchiolla, MD, Elisabetta Todisco, MD PhD, Andrea Bilancia, Sara Gandolfi, MD, Valentina Mancini, MD, Laura Marbello, MD, Massimo Bernardi, MD, Andrea Assanelli, MD, Nicola Orofino, MD, Ramona Cassin, MD, Mariarita Sciumè, MD, Francesca Guidotti, MD, Roberto Cairoli, MD, Fabio Ciceri, MD, Armando Santoro, MD, Agostino Cortelezzi, MD, Giuseppe Rossi, MD

Blood (2015) 126 (23): 5611.

https://doi.org/10.1182/blood.V126.23.5611.5611

Published: 2015

Journal Articles

Establishment of a Mouse Model of Aplastic Anemia Complicated By Iron Overload

Dijiong Wu, M.M., Xiaowen Wen, M.M., Baodong Ye, MD PhD, Wenbin Liu, M.M., Yanting Gao, M.M., Yiping Shen, BA, Yuhong Zhou, M.M., Jie Jin, MD PhD

Blood (2015) 126 (23): 4555.

https://doi.org/10.1182/blood.V126.23.4555.4555

Published: 2015

Journal Articles

Low-Dose Deguelin, Selective Targeting of Mt NPM1, Induces Differentiation in NPMc+ AML Cells By Regulation the Axis of SIRT1/CEBPβ/G-CSFR, Instead of HDAC1/3

Youping Wang, Zichu Zhao, Jingyu Hu, Fei Zhao, Jing He, Jun Fang, Chun Zhang, Guohui Cui, Yan Chen

Blood (2014) 124 (21): 2231.

https://doi.org/10.1182/blood.V124.21.2231.2231

Published: 2014

Journal Articles

Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin

Daniela Pietra, PhD, Elisa Rumi, MD, Chiara Milanesi, BS, Christian A Di Buduo, PhD, Marta Bellini, MD, Ilaria Carola Casetti, MD, Chiara Cavalloni, MD, Emanuela Sant'Antonio, Vittorio Abbonante, PhD, Maria C Renna, BS, Virginia Ferretti, PhD, Emanuela Boveri, MD, Alessandra Balduini, MD, Cristiana Pascutto, PhD, Mario Cazzola, MD

Blood (2014) 124 (21): 3215.

https://doi.org/10.1182/blood.V124.21.3215.3215

Published: 2014

Journal Articles

Intravital Imaging of Pulmonary Neutrophils in Sickle Cell Anemia

Natacha Ralainirina, PhD, Grzegorz Chodaczek, PhD, Joel Linden, PhD

Blood (2014) 124 (21): 1398.

https://doi.org/10.1182/blood.V124.21.1398.1398

Published: 2014

Journal Articles

Role of Epigenetic Readers in Pathogenesis and Therapy of Acute Leukemias

Brian J. P. Huntly, MD, PhD

Blood (2013) 122 (21): SCI-20.

https://doi.org/10.1182/blood.V122.21.SCI-20.SCI-20

Published: 2013

Journal Articles

A Specific Mechanism By Which NPM1 mutations Impede Myeloid Differentiation Also Explains The Link With DNMT3A Mutation

Xiaorong Gu, PhD, Reda Z Mahfouz, MD/PhD, Francis Enane, MS, Zhenbo Hu, MD, PhD, Michael J. Clemente, Bartlomiej P Przychodzen, PhD, Mikkael A. Sekeres, MD, MS, Anjali S. Advani, MD, Matt Kalaycio, MD, Jaroslaw P. Maciejewski, MD, PhD, Yogen Saunthararajah, M.D.

Blood (2013) 122 (21): 1254.

https://doi.org/10.1182/blood.V122.21.1254.1254

Published: 2013

Journal Articles

Extra-Nuclear Dislocation of PU.1 but Not CEBPA by Mutated NPM1 in AML Explains Lineage-Associations, ATRA Therapeutic Potential and DNMT3A Secondary Mutation.

Xiaorong Gu, PhD, Reda Z Mahfouz, MD/PhD, Zhenbo Hu, MD, PhD, Yogenthiran Saunthararajah, MD

Blood (2012) 120 (21): 2427.

https://doi.org/10.1182/blood.V120.21.2427.2427

Published: 2012

Journal Articles

Celastrol Overcomes Chemoresistance in Vitro and Potentiates the Effect of Bortezomib Against Human Multiple Myeloma in Nude Mice Mode

Radhamani Kannaiyan, Manu Kanjoormana Aryan, Muthu K Shanmugam, Feng Li, Gautam Sethi

Blood (2012) 120 (21): 5017.

https://doi.org/10.1182/blood.V120.21.5017.5017

Published: 2012

Journal Articles

A “canonical” Npm1 mutation Knock-in Mouse Model Revealed Subtle but Definitive Myeloid Expansion with Poor HSC Niche Interaction

Wen-Chien Chou, MD, PhD, Shiu-Huey Chou, PhD, Ji-Shain Chiou, Bor-Sheng Ko, Shu-Wha Lin, PhD, Yueh-Chwen Hsu, Hwei-Fang Tien, MD, PhD

Blood (2011) 118 (21): 762.

https://doi.org/10.1182/blood.V118.21.762.762

Published: 2011

Journal Articles

Reversal of Multidrug Resistance by Magnetic Fe 3 O 4 Nanoparticle Loading Daunorubicin and Bromotetrandrine in Nude Mice Bearing Leukemia Tumor Xenografts

Yan-Yan Ren, Bao-An Chen, MD, PhD, Xiao-hui Cai, Ran Liu, Wei-wei Wu

Blood (2011) 118 (21): 5013.

https://doi.org/10.1182/blood.V118.21.5013.5013

Published: 2011

Journal Articles

Dissecting the Hierarchical Level of Hematopoietic Progenitors' Involvement in AML with NPM1 Gene Mutation and Their Engraftment Potential in Immunocompromised Mice.

Blood (2009) 114 (22): 480.

https://doi.org/10.1182/blood.V114.22.480.480

Published: 2009

Journal Articles

Long-Term Expansion and Self Renewal Is Contained in the CD34+, but Not the CD34- Subfraction of Nucleophosmin Mutated Acute Myeloid Leukemia Cells.

Carolien Woolthuis, Lina Han, Djoke van Gosliga, Philip Kluin, MD, PhD, Edo Vellenga, MD, PhD, Jan J. Schuringa, PhD, Geert Huls, MD, PhD

Blood (2008) 112 (11): 1349.

https://doi.org/10.1182/blood.V112.11.1349.1349

Published: 2008

Journal Articles

A Rapid Flow Cytometric Method for the Detection of NPM1 Mutated Patients with Acute Myeloid Leukemia (AML).

Uta Oelschlaegel, PhD, Sina Koch, PhD, Markus Schaich, MD, Frank Kroschinsky, MD, Stefani Parmentier, MD, Gerhard Ehninger, MD, Christian Thiede, MD

Blood (2008) 112 (11): 1490.

https://doi.org/10.1182/blood.V112.11.1490.1490

Published: 2008

Journal Articles

Phase I Study of S-trans, Trans-farnesylthiosalicylic Acid (FTS), a Novel Oral Ras Inhibitor, in Patients with Refractory Hematologic Malignancies.

Gautam Borthakur, MD, Farhad Ravandi, MD, Susan O’Brien, MD, Miloslav Beran, MD, Betsy Williams, RN, Howard Goldsweig, MD, Francis Giles, MD

Blood (2007) 110 (11): 1600.

https://doi.org/10.1182/blood.V110.11.1600.1600

Published: 2007

Journal Articles

Reciprocal Interaction between NPM Leukemic Mutants and Arf: Structural Basis and Functional Consequences.

Niccolo’ Bolli, Maria Paola Martelli, Barbara Bigerna, Alessandra Pucciarini, Barbara Verducci, Teresa Pallotta, Felicetta de Marco, Valentina Pettirossi, Roberta Mannucci, Elisabetta Bonifacio, Antonio Tabilio, Ildo Nicoletti, Brunangelo Falini

Blood (2006) 108 (11): 1939.

https://doi.org/10.1182/blood.V108.11.1939.1939

Published: 2006

NARROW

PICC Insertion and Management in Hodgkin Lymphoma Patients: A 10-YEARS Monocentric Prospective Study

The Long-Term Adverse Event Profile of Oral Eliglustat for the Treatment of Gaucher Disease Type 1: Pooled Analysis of Data from 393 Patients in 4 Completed Trials

Identification and Characterization of Novel Rare Nucleophosmin ( NPM1 ) Gene Mutations in Acute Myeloid Leukemia (AML) By a Combinatorial Approach of Immunohistochemistry and Molecular Analyses

Deguelin Induced Differentiation of NPM1-Mutant AML In Vivo and in Vitro

Peripherally Inserted Central Catheters (PICCs) Implantation in the Clinical Management of Oncohematologic Patients: Results of a Large Multicenter, Retrospective Study of the REL Group (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)

Establishment of a Mouse Model of Aplastic Anemia Complicated By Iron Overload

Low-Dose Deguelin, Selective Targeting of Mt NPM1, Induces Differentiation in NPMc+ AML Cells By Regulation the Axis of SIRT1/CEBPβ/G-CSFR, Instead of HDAC1/3

Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin

Intravital Imaging of Pulmonary Neutrophils in Sickle Cell Anemia

Role of Epigenetic Readers in Pathogenesis and Therapy of Acute Leukemias

A Specific Mechanism By Which NPM1 mutations Impede Myeloid Differentiation Also Explains The Link With DNMT3A Mutation

Extra-Nuclear Dislocation of PU.1 but Not CEBPA by Mutated NPM1 in AML Explains Lineage-Associations, ATRA Therapeutic Potential and DNMT3A Secondary Mutation.

Celastrol Overcomes Chemoresistance in Vitro and Potentiates the Effect of Bortezomib Against Human Multiple Myeloma in Nude Mice Mode

A “canonical” Npm1 mutation Knock-in Mouse Model Revealed Subtle but Definitive Myeloid Expansion with Poor HSC Niche Interaction

Reversal of Multidrug Resistance by Magnetic Fe 3 O 4 Nanoparticle Loading Daunorubicin and Bromotetrandrine in Nude Mice Bearing Leukemia Tumor Xenografts

Dissecting the Hierarchical Level of Hematopoietic Progenitors' Involvement in AML with NPM1 Gene Mutation and Their Engraftment Potential in Immunocompromised Mice.

Long-Term Expansion and Self Renewal Is Contained in the CD34+, but Not the CD34- Subfraction of Nucleophosmin Mutated Acute Myeloid Leukemia Cells.

A Rapid Flow Cytometric Method for the Detection of NPM1 Mutated Patients with Acute Myeloid Leukemia (AML).

Phase I Study of S-trans, Trans-farnesylthiosalicylic Acid (FTS), a Novel Oral Ras Inhibitor, in Patients with Refractory Hematologic Malignancies.

Reciprocal Interaction between NPM Leukemic Mutants and Arf: Structural Basis and Functional Consequences.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only